Semaglutide is normally very well tolerated with very similar dropout costs when put next with placebo, even though it could possibly be significantly less effectively tolerated than dulaglutide (Trulicity).1,3 The commonest adverse results are nausea, vomiting, and diarrhea and can be knowledgeable by about 30% of patients, typically in the event